Clinical trial
Depression and Traumatic Brain Injury
NCT00254007 · Sunnybrook Health Sciences Centre, Other · Completed
Key facts
| NCT number | NCT00254007 |
|---|---|
| Title | Depression and Traumatic Brain Injury |
| Official title | The Serotonin Transporter Gene Polymorphism and Major Depression Following Traumatic Brain Injury |
| Lead sponsor | Sunnybrook Health Sciences Centre, Other |
| Collaborators | Ontario Mental Health Foundation |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depression, Traumatic Brain Injury |
| Intervention type | Drug |
| Interventions | citalopram (celexa) |
| Enrollment | 200 |
| Start date | Jul 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | May 1, 2010 |
| First posted | Nov 15, 2005 |
| Last update posted | Apr 28, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: